Medicina preventiva

2024

1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

   Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

2. Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis

   JMIR public health and surveillance, Vol. 10, pp. e54503

3. Clinical profile, management and outcomes of patients with cardiogenic shock undergoing transfer between centers in Spain

   Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 226-233

4. Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection

   Infectious Diseases

5. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease

   Clinical Kidney Journal, Vol. 17, Núm. 6

6. Dentists' knowledge, attitudes and perceptions of antibiotic prescribing: A systematic review

   Preventive Medicine, Vol. 185

7. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

   The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

8. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

   Journal of Clinical Medicine, Vol. 13, Núm. 9

9. Epidemiological aspects, clinical management and short-term outcomes in elderly patients diagnosed with acute heart failure in the emergency department in Spain: results of the EDEN-34 study

   Revista Clinica Espanola, Vol. 224, Núm. 4, pp. 204-216

10. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264

11. Gender differences in clinical features and outcomes of patients over 75 years presenting with acute heart failure. Results of a nationwide study (2016-2019)

    Cardiology journal, Vol. 31, Núm. 3, pp. 427-433

12. Genome Wide Association Studies in Small-Cell Lung Cancer. A Systematic Review

    Clinical Lung Cancer, Vol. 25, Núm. 1, pp. 9-17

13. Hospital admissions and outcomes for systolic and diastolic heart failure in Spain between 2016 and 2019: A population-based study

    Medicina Clinica, Vol. 162, Núm. 5, pp. 213-219

14. Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry

    The Journal of rheumatology, Vol. 51, Núm. 9, pp. 877-883

15. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure

    ESC Heart Failure, Vol. 11, Núm. 3, pp. 1739-1747

16. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612

17. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

18. Predicting the Length of Mechanical Ventilation in Acute Respiratory Disease Syndrome Using Machine Learning: The PIONEER Study

    Journal of Clinical Medicine, Vol. 13, Núm. 6

19. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

20. Temporal progression of the distribution of Streptococcus pneumoniae serotypes causing invasive pneumococcal disease in Galicia (Spain) and its relationship with resistance to antibiotics (period 2011-2021)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 179-186